{"nct_id":"NCT06692738","title":"A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)","status":"RECRUITING","status_verified_date":"2025-07","start_date":"2024-11-18","start_date_type":"ACTUAL","primary_completion_date":"2029-02-05","primary_completion_date_type":"ESTIMATED","completion_date":"2029-10-08","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}